v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)        
Product revenue $ 4,715,874 $ 5,092,123 $ 10,637,304 $ 11,479,147
License revenue 2,600,000 133,125 3,125,000 273,750
Other revenue 46,015 11,742 74,507 87,292
Revenues 7,361,889 5,236,990 13,836,811 11,840,189
Cost of sales (3,329,638) (3,642,071) (7,602,136) (8,056,386)
Gross profit 4,032,251 1,594,919 6,234,675 3,783,803
Operating expenses:        
Research and development expenses (473,303) 0 (1,335,464) 0
Selling, general and administrative expenses (related party of $112,500, $269,467, $337,500 and $635,864) (2,748,100) (2,702,350) (6,616,663) (10,863,236)
Total operating expenses (3,221,403) (2,702,350) (7,952,127) (10,863,236)
Operating income (loss) 810,848 (1,107,431) (1,717,452) (7,079,433)
Other income (expense)        
Interest expense (related party of $Nil, $Nil, $Nil and $245,817) 0 (7,356) (54) (258,990)
Loss on change in fair value of profit share and unsecured note (37,619) 282,382 (766,667) (2,672,252)
Interest income 15,412 80,656 66,222 257,483
Total other income (expense) (22,207) 355,682 (700,499) (2,673,759)
Income (Loss) before provision for income taxes 788,641 (751,749) (2,417,951) (9,753,192)
(Provision for) benefit from income taxes (629) 294,203 (15,173) 293,857
Net income (loss) $ 788,012 $ (457,546) $ (2,433,124) $ (9,459,335)
Net income (loss) per common share        
Basic net income (loss) per share $ 0.01 $ (0.00) $ (0.03) $ (0.10)
Diluted net income (loss) per share $ 0.01 $ (0.00) $ (0.03) $ (0.10)
Weighted average common shares outstanding Basic 96,866,109 96,125,797 96,449,742 94,992,520
Weighted average common shares outstanding Diluted 98,000,381 96,125,797 96,449,742 94,992,520

Source